This Vaccine Stock Soars 46% After $1.1 Billion AstraZeneca Deal

Icosavax stock soared 46% in Tuesday premarket trading after the Seattle-based vaccine developer reached a deal to be acquired by pharmaceutical giant AstraZeneca.

#seattle #astrazeneca